Funder
Prostate Cancer Foundation
National Science Foundation
Astellas Pharma US
National Institutes of Health
Institute for Prostate Cancer Research
American Cancer Society
Congressionally Directed Medical Research Programs
National Cancer Institute
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference25 articles.
1. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen;Israeli;Cancer Res,1993
2. Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer;Sartor;N Engl J Med,2021
3. [68Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [177Lu]Lu-PSMA-617 treatment;Peters;Eur J Nucl Med Mol Imaging,2022
4. Personalized therapy planning for 177Lu-DOTATATE using a kidney-driven dose optimization method;Mirando;J Nucl Med,2019
5. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment;Sandström;J Nucl Med,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combinatorial Therapies: Embracing Our Multifaceted Future;International Journal of Radiation Oncology*Biology*Physics;2024-04